Ziegler Capital Management, LLC Vanda Pharmaceuticals Inc. Transaction History

Ziegler Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 24, 2023	SELL	$6.87 - $10.96 $50,968 - $81,312	-7,419 Reduced 18.91%	31,806 $0
Q3 2022 Oct 25, 2022	SELL	$9.44 - $11.76 $2,161 - $2,693	-229 Reduced 0.58%	39,225 $388,000
Q2 2022 Jul 21, 2022	BUY	$9.31 - $11.84 $9,458 - $12,029	1,016 Added 2.64%	39,454 $430,000
Q1 2022 May 04, 2022	SELL	$10.84 - $16.55 $34,688 - $52,960	-3,200 Reduced 7.69%	38,438 $435,000
Q4 2021 Feb 09, 2022	SELL	$15.69 - $21.14 $212,881 - $286,827	-13,568 Reduced 24.58%	41,638 $653,000
Q3 2021 Oct 27, 2021	SELL	$15.35 - $21.27 $28,858 - $39,987	-1,880 Reduced 3.29%	55,206 $946,000
Q2 2021 Jul 21, 2021	BUY	$15.71 - $21.51 $26,361 - $36,093	1,678 Added 3.03%	57,086 $1.23 Million
Q1 2021 Apr 29, 2021	SELL	$13.42 - $20.28 $19,687 - $29,750	-1,467 Reduced 2.58%	55,408 $832,000
Q4 2020 Feb 05, 2021	BUY	$9.77 - $13.81 $555,668 - $785,443	56,875 New	56,875 $747,000

161

45.2M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $278M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Ziegler Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Ziegler Capital Management, LLC with notifications on news.